Related Experiment Videos
Axonal damage in multiple sclerosis patients with high versus low expanded disability status scale score
Steven D Brass1, Sridar Narayanan, Jack P Antel
1Montreal Neurological Hospital, Department of Neurology and Neurosurgery, Montreal, Quebec, Canada.
Summary
Spinal cord atrophy, not brain atrophy, differentiates multiple sclerosis disability levels. This suggests localized spinal cord damage contributes more to severe disability than widespread brain pathology.
Area of Science:
- Neurology
- Neuroimaging
- Pathophysiology
Background:
- The underlying reasons for varying disability levels in multiple sclerosis (MS) patients remain poorly understood.
- Investigating the pathophysiological basis of MS disability is crucial for targeted therapeutic strategies.
Purpose of the Study:
- To investigate if a more destructive disease process underlies greater disability in MS patients with similar lesion volume and disease duration.
- To differentiate the pathological basis of benign versus severe disability in multiple sclerosis.
Main Methods:
- Utilized magnetic resonance imaging (MRI) techniques, including magnetic resonance spectroscopy (MRS).
- Compared brain atrophy metrics and N-acetylaspartate (NAA) levels in normal-appearing white matter between patient cohorts.
- Assessed spinal cord atrophy in relation to disability severity.
Main Results:
- Severely disabled MS patients exhibited similar brain atrophy and cerebral white matter NAA levels compared to benign MS patients.
- A significant finding was greater spinal cord atrophy in the severely disabled cohort.
- These results indicate a dissociation between cerebral and spinal cord pathology in relation to disability.
Conclusions:
- The observed differences in spinal cord atrophy, contrasted with similar cerebral atrophy, suggest that disability progression in MS is not driven by a uniformly aggressive pathological process across the entire neuroaxis.
- Spinal cord pathology may play a more critical role in determining severe disability in MS than previously recognized.
- These findings highlight the importance of considering regional neurodegenerative processes in MS.